Sector News

Stryker acquires single-use device reprocessor Hygia Health Services

May 2, 2018
Life sciences

Stryker said today it acquired single-use-device reprocessor Hygia Health Services for an undisclosed amount.

Birmingham, Ala.-based Hygia has partnered with Kalamazoo, Mich.-based Stryker since 2015 to reprocess single-use devices, and Stryker said the acquisition will “further solidify the partnership.”

Stryker said that Hygia’s product portfolio of air transfer mattresses, fall alarms, ECG leads, cerebral-somatic sensors and infusor bags will help broaden its reprocessing offerings. Stryker said that it reprocessed approximately 3,000 single-use devices in 2017, with estimated savings of approximately $326 million.

“In line with our commitment to help hospitals and health systems increase the value their SUD reprocessing programs deliver, this acquisition will enhance our ability to deliver savings to our customers. Furthermore, our broader product portfolio will help customers elevate their sustainability goals and set a higher bar for sustainable healthcare delivery,” Stryker sustainability solutions prez Brian White said in a prepared statement.

Last week, Stryker saw shares fall slightly after it posted first quarter earnings that topped Wall Street expectations but saw sales shrink slightly.

By Fink Densford

Source: MassDevice

comments closed

Related News

July 3, 2022

Novo Nordisk joins with nursing group to highlight correlation between Type 2 diabetes and cardio risk

Life sciences

Despite atherosclerotic cardiovascular disease (ASCVD) being the leading cause of death for people with Type 2 diabetes, half of those people have no idea of this risk. Novo Nordisk has teamed up with the Preventive Cardiovascular Nurses Association (PCNA) for “Making the Connection,” a program to help increase understanding of the link between the two diseases.

July 3, 2022

First treatment for ‘broken heart syndrome’ trialled

Life sciences

The first ever treatment for broken heart syndrome – also known as Takotsubo cardiomyopathy – is to be trialled by researchers at the University of Aberdeen. Scientists will trial a programme of exercise conditioning and psychological therapy for people who have been diagnosed with the condition following a £300,000 grant from the British Heart Foundation.

July 3, 2022

Nestlé acquiring The Better Health Company in market expansion deal

Life sciences

Nestlé Health Science is set to acquire The Better Health Company (TBHC), as part of its goals to grow global market share while spurring innovation across the nutrition industry. The acquisition includes the GO Healthy brand with its vitamins and supplements, Egmont, the Manuka honey brand and New Zealand Health Manufacturing, an Auckland-based manufacturing facility for vitamins minerals and supplements.